Daryn Reeder, | |
815 Ritchie Hwy Ste 118, Severna Park, MD 21146-4192 | |
(844) 410-2878 | |
Not Available |
Full Name | Daryn Reeder |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 815 Ritchie Hwy Ste 118, Severna Park, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1194338624 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 02152L (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Daryn Reeder, 815 Ritchie Hwy Ste 118, Severna Park, MD 21146-4192 Ph: (844) 410-2878 | Daryn Reeder, 815 Ritchie Hwy Ste 118, Severna Park, MD 21146-4192 Ph: (844) 410-2878 |
News Archive
OSI Pharmaceuticals, Inc., Genentech, Inc., and Roche announced today that results from a randomized Phase III clinical study of the investigational drug Tarceva (erlotinib HCl), in combination with gemcitabine chemotherapy met its primary endpoint of improving survival.
NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today announced that president and chief executive officer Francois Nader, M.D. has received the Ernst & Young Entrepreneur Of The Year® 2013 Award in the Life Sciences category in New Jersey. Dr. Nader was presented with the award at a special gala event on June 13 at the Hyatt Regency New Brunswick, New Jersey.
A new link between meal times and daily changes in the immune system has been identified by UC San Francisco researchers, and has led them to question assumptions about the roles of specific immune cells in infection and allergy.
Orexigen Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced progress with the United States Food and Drug Administration (FDA) on a faster path to resubmission of the Contrave (naltrexone SR / bupropion SR) New Drug Application (NDA).
› Verified 7 days ago
Miss Kaitlyn Ashley Sikkema, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 645 Baltimore Annapolis Blvd, Ste 111, Severna Park, MD 21146 Phone: 410-544-2500 Fax: 410-384-9703 | |
Mrs. Nancy Beasley, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 645 Baltimore Annapolis Blvd, Ste 111, Severna Park, MD 21146 Phone: 410-544-2500 | |
Lisa J Remer, MS,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 24 Truck House Rd, Severna Park, MD 21146 Phone: 410-544-4220 Fax: 410-647-9484 | |
Amy Curtin, SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 645 Baltimore Annapolis Blvd Ste 212, Severna Park, MD 21146 Phone: 410-544-2500 | |
Francis Nochera Iv, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 350 Baltimore Annapolis Blvd, Severna Park, MD 21146 Phone: 410-647-1503 | |
Mrs. Kara Lynn Rice, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 645 Baltimore Annapolis Blvd, 111, Severna Park, MD 21146 Phone: 410-544-2500 Fax: 410-384-9703 | |
Christina T Whitlock, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 645 Baltimore Annapolis Blvd Ste 111, Severna Park, MD 21146 Phone: 410-544-2500 |